Pharma Deals Review, Vol 2003, No 33 (2003)

Font Size:  Small  Medium  Large

Schering AG to Market Campath® in South East Asia

Business Review Editor

Abstract


Schering AG has acquired exclusive rights to develop, sell and distribute Ilex Oncology’s humanized monoclonal antibody Campath (alemtuzumab) in Japan, China and the Asian Pacific Basin.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.